Every Form 4 that Ormat Tech (ORA) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A Form 4 covers the transactions officers, directors and large holders report, so if you follow ORA and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full ORA filings page.
Ormat Technologies executive Willis Aron John reported routine equity compensation activity. On June 30, 2026, 1,812 restricted stock units vested, converting into the same number of Ormat common shares as part of a three-year vesting schedule. Each RSU delivers one share upon vesting.
On July 1, 2026, 451 of these common shares were sold in open-market transactions at an average price of $106.64 per share to satisfy the reporting person’s tax withholding obligations related to the vesting. Following these transactions, he directly holds 1,361 shares of Ormat common stock.
Angel Isaac reported acquisition or exercise transactions in this Form 4 filing.
ORMAT TECHNOLOGIES, INC. reported that director Angel Isaac received a grant of 1,245 Restricted Stock Units (RSUs) on June 2, 2026. Each RSU represents the right to receive one share of Ormat common stock when it vests.
The entire RSU grant is scheduled to vest 100% on June 2, 2027, the one-year anniversary of the grant date. Following this grant, Isaac holds 1,245 RSUs directly. This is a compensation-related equity award, not an open‑market share purchase or sale.
STERN STANLEY reported acquisition or exercise transactions in this Form 4 filing.
ORMAT TECHNOLOGIES, INC. director Stanley Stern reported a compensation-related grant of 899 Restricted Stock Units (RSUs). Each RSU represents the right to receive one share of Ormat common stock upon vesting, so this award aligns his incentives with shareholders through future equity.
The RSU grant was made on June 2, 2026 and will vest 100% on June 2, 2027, the one-year anniversary of the grant date. Following this transaction, Stern’s reported derivative holdings from this grant total 899 RSUs, with no open‑market purchases or sales disclosed in this filing.
Wong Byron G. reported acquisition or exercise transactions in this Form 4 filing.
Ormat Technologies director Byron G. Wong reported an equity award of 899 restricted stock units (RSUs). These RSUs were granted as compensation and carry no purchase price. Each RSU represents the right to receive one share of Ormat common stock upon vesting.
The filing states that this block of 899 RSUs will vest 100% on June 2, 2027, the one-year anniversary of the grant date. Following this grant, Wong holds 899 RSUs directly, highlighting a modest, routine alignment of his compensation with future company performance.
SHARIR DAFNA reported acquisition or exercise transactions in this Form 4 filing.
ORMAT TECHNOLOGIES, INC. director Dafna Sharir received a grant of 899 Restricted Stock Units (RSUs) on June 2, 2026. Each RSU represents the right to receive one share of Ormat common stock upon vesting. This entire RSU grant will vest 100% on June 2, 2027, and the filing shows 899 derivative units held following the award.
Barniv Ravit reported acquisition or exercise transactions in this Form 4 filing.
ORMAT TECHNOLOGIES, INC. director Ravit Barniv received a grant of 899 Restricted Stock Units, each representing one share of ORA common stock upon vesting. The entire RSU award is scheduled to vest 100% on June 2, 2027, one year after the grant date.
Marom Michal reported acquisition or exercise transactions in this Form 4 filing.
ORMAT TECHNOLOGIES, INC. director Michal Marom received a grant of 899 Restricted Stock Units on June 2, 2026. Each RSU represents one share of ORA common stock upon vesting. This entire RSU grant is scheduled to vest 100% on June 2, 2027, and Marom now holds 899 RSUs directly.
Corfee Karin reported acquisition or exercise transactions in this Form 4 filing.
ORMAT TECHNOLOGIES, INC. director Karin Corfee received a grant of 899 Restricted Stock Units as equity compensation. Each RSU represents the right to receive one share of ORA common stock upon vesting. This entire RSU grant will vest 100% on June 2, 2027, and Corfee now holds 899 RSUs following the award.
Granot David reported acquisition or exercise transactions in this Form 4 filing.
ORMAT TECHNOLOGIES, INC. director David Granot reported a new equity compensation award. He received a grant of 899 Restricted Stock Units, each representing the right to receive one share of Ormat common stock upon vesting. These RSUs vest 100% on June 2, 2027, which is the one-year anniversary of the grant date. Following this grant, Granot holds 899 RSUs directly, and the filing does not report any open-market stock purchases or sales, only this compensation-related award.
Ormat Technologies director Stanley Stern reported an open-market sale of 250 shares of common stock on May 27, 2026. The shares were sold at a weighted average price of $138.42 per share, in multiple trades between $138.38 and $138.49, leaving him with 5,800 shares owned directly.
Ormat Technologies director Michal Marom sold shares in an open-market trade. On May 19, 2026, Marom sold 3,080 shares of Ormat Technologies common stock in an open-market transaction at an average price of $130.975 per share. After the sale, Marom directly holds 1,766 shares of the company’s common stock.
Ormat Technologies director David Granot sold 3,519 shares of Common Stock in two open‑market transactions. He sold 1,753 shares at $132.70 per share on May 20, 2026, and 1,766 shares at $134.425 per share on May 21, 2026. These sales reduced his directly held Ormat shares to zero, and the filing shows no remaining derivative positions.
ORMAT TECHNOLOGIES, INC. director David Granot reported a combination of equity award activity and share sales. He exercised 1,315 Stock Appreciation Rights at an exercise price of $67.54 per share when the market price was $73.84, which generated 112 net shares after 1,203 shares were disposed of to the issuer for tax withholding related to the exercise. On the same date, he then sold a total of 950 shares of common stock in multiple open-market transactions at prices between $72.99 and $73.84. Following these transactions, he directly owned 2,825 shares of Ormat common stock. This Form 4 amendment corrects an earlier filing that had omitted the SAR exercise and tax-related disposition and had misclassified 112 net shares as an open-market sale.
ORMAT TECHNOLOGIES, INC. executive vice president Benyosef Ofer reported a combination of stock option–style exercises and share sales in company common stock. He exercised 1,101 Stock Appreciation Rights with an exercise price of $71.15 per share, which resulted in 499 shares of common stock being issued and 602 shares effectively returned to the issuer as part of the SAR settlement mechanics. On the same date, he sold 9,429 shares of common stock in open-market transactions at $131.02 per share under a pre-arranged Rule 10b5-1 trading plan, and after these transactions he no longer directly holds Ormat common stock.
Ormat Technologies director Stanley Stern sold shares in a routine open-market transaction. On May 15, 2026, he sold 577 shares of Ormat Technologies common stock at a price of $130.17 per share. After this sale, he directly holds 6,050 common shares, indicating he retains a substantial position despite the relatively small disposition.
Ormat Technologies’ Chief Financial Officer Assi Ginzburg reported a combination of option exercises and share sales in Common Stock. On May 14, 2026, he exercised 5,502 Stock Appreciation Rights at an exercise price of $71.15 per share, converting them into Common Stock. The filing states that only 2,559 shares of Common Stock were issued from this SAR exercise, based on the difference between the market value of $133.118 and the exercise price. The CFO then disposed of shares through an issuer-related transaction and open-market sales totaling 17,776 shares at weighted average prices of $133.118 and $135.019 per share, across price ranges from $133.02 to $135.265. Following these transactions, he directly holds 1,970 shares of Ormat Technologies Common Stock.
ORMAT TECHNOLOGIES, INC. director Byron G. Wong reported an open-market sale of common stock. On May 13, 2026, he sold 4,500 shares of Ormat common stock at $134.32 per share. After this transaction, Wong directly owned 5,925 shares of Ormat common stock, and no derivative positions were reported in this filing.
Ormat Technologies director Dafna Sharir reported a combination of equity vesting and a small share sale. On May 7, 2026, 1,766 Restricted Stock Units vested, converting into the same number of Ormat common shares. On May 11, 2026, she then sold 883 common shares in an open-market transaction at $122.44 per share, executed under a pre-arranged Rule 10b5-1 trading plan adopted on November 18, 2025. Following these transactions, Sharir directly holds 3,140 shares of Ormat common stock.
ORMAT TECHNOLOGIES, INC. director Byron G. Wong acquired 1,766 shares of common stock through the vesting and exercise of Restricted Stock Units. The RSUs, each representing one share of common stock, vested 100% on May 7, 2026, one year after grant. Following this non-cash, compensation-related exercise, Wong directly holds 10,425 shares of Ormat common stock. No open-market purchases or sales were reported in this filing.
ORMAT TECHNOLOGIES, INC. director Stanley Stern reported the vesting and settlement of restricted stock units into common shares. On May 7, 2026, 1,766 Restricted Stock Units vested and were converted into 1,766 shares of common stock. Following this equity-based compensation event, Stern holds 6,627 shares of Ormat common stock directly.
ORMAT TECHNOLOGIES, INC. director Ravit Barniv reported the vesting and exercise of restricted stock units into common shares. On May 7, 2026, 1,766 Restricted Stock Units vested in full on the first anniversary of the grant, and were converted into 1,766 shares of common stock. After this derivative exercise, Barniv directly holds 1,766 shares of Ormat common stock, with no remaining RSU position shown in this filing.
ORMAT TECHNOLOGIES, INC. director Michal Marom reported a routine equity compensation event. On May 7, 2026, 1,766 Restricted Stock Units vested and were exercised into 1,766 shares of common stock at an exercise price of $0.00 per share. Following this conversion, Marom directly owns 4,846 shares of Ormat common stock, and the reported RSU award has been fully settled into shares.
ORMAT TECHNOLOGIES, INC. director Karin Corfee exercised Restricted Stock Units that vested into 1,766 shares of common stock. These RSUs represented the right to receive one common share per unit, and on May 7, 2026, 100% of the units vested. Following this conversion, Corfee holds 6,427 common shares directly. The filing shows no open-market purchases or sales, only the vesting and settlement of equity compensation.
ORMAT TECHNOLOGIES, INC. director Angel Isaac exercised restricted stock units that vested into common shares. On May 7, 2026, 2,445 restricted stock units converted into 2,445 shares of common stock at a stated price of $0.00 per share. Following this vesting, Isaac directly holds 32,095 shares of Ormat common stock.
Ormat Technologies director David Granot exercised restricted stock units into common shares. On May 7, 2026, he converted 1,766 Restricted Stock Units into 1,766 shares of Ormat common stock at a stated price of $0.00 per share, reflecting routine equity compensation vesting. Following this transaction, Granot directly holds 3,407 shares of Ormat common stock. The filing shows no open‑market purchases or sales, only the vesting and settlement of previously granted RSUs, which is a standard form of non-cash director compensation.
Ormat Technologies, Inc. general counsel, chief compliance officer, and corporate secretary Jessica Woelfel reported open-market sales of a total of 3,927 shares of common stock. The transactions occurred on March 25–26, 2026 at prices around $107–$110 per share.
Part of the March 25 activity was an automatic sell-to-cover transaction mandated by an award agreement to satisfy tax withholding on restricted stock units that vested on March 21, 2026. The remaining sales on March 25 and March 26 were executed under a pre-arranged Rule 10b5-1 trading plan adopted on June 30, 2025 and modified on November 25, 2025.
Following these sales, Woelfel directly holds 3,433 shares of Ormat common stock.
ORMAT TECHNOLOGIES, INC. Chief Financial Officer Assi Ginzburg reported equity compensation activity tied to previously granted awards. On March 21, 2026, 1,064 restricted stock units vested, converting into 1,064 shares of common stock, and performance stock units granted on March 21, 2023 reached their performance vesting.
The performance stock units vested based on 75% achievement of the relative total stockholder return goal and 200% of the megawatt capacity goal. As a result, 6,611 performance stock units were paid out in common shares, while 2,205 units remain outstanding as restricted stock units, subject to time-based vesting through the fourth anniversary of the grant date.
ORMAT TECHNOLOGIES, INC. Chief Executive Officer Doron Blachar reported compensation-related equity activity tied to restricted and performance stock units. On March 21, 2026, 2,252 restricted stock units vested, delivering an equal number of common shares.
On the same date, performance stock units granted on March 21, 2023 performance vested based on 75% achievement of relative total stockholder return goals and 200% achievement of megawatt capacity goals. This resulted in 13,999 performance stock units paying out immediately in common stock, with 4,667 units converting into time-vesting restricted stock units that will vest on the fourth anniversary of the grant, contingent on continued service.
Following these exercises and awards, Blachar directly held 62,734 shares of common stock and 4,667 restricted stock units. The filing shows only acquisitions and vesting events, with no open-market purchases or sales.
ORMAT TECHNOLOGIES, INC. general counsel, chief compliance officer, and corporate secretary Jessica Woelfel reported equity compensation activity and a small related share sale. On March 21, 2026, 563 restricted stock units vested, each converting into one share of common stock. On the same date, performance stock units granted on March 21, 2023 performance-vested based on 75% achievement of relative total stockholder return goals and 200% achievement of megawatt capacity goals, leading to an immediate payout of 3,500 shares, with the remaining 1,168 units continuing as RSUs subject to time-based vesting.
Following these transactions, Woelfel held 7,496 shares of common stock directly before a subsequent automatic sell-to-cover transaction. On March 24, 2026, 136 shares of common stock were sold in the open market at a price of $107.79 per share as a non-discretionary sale mandated by the award agreement to satisfy tax withholding obligations tied to the March 21 vesting events. After this small sale, her direct common stock holdings were 7,360 shares.
Ormat Technologies EVP Energy Storage & BD Benyosef Ofer reported equity compensation activity centered on performance stock units and restricted stock units. On March 21, 2026, 626 restricted stock units vested, converting into 626 shares of common stock. Following this, he directly held 5,044 common shares from that transaction and 626 restricted stock units tied to that vesting cycle.
On the same date, performance stock units granted on March 21, 2023 performance vested based on achieving 75% of relative total stockholder return goals and 200% of megawatt capacity goals. As a result, 3,888 performance stock units were immediately paid out in common stock, bringing direct common stock holdings reported after this transaction to 8,932 shares. The remaining 1,296 performance stock units became time-vesting restricted stock units, representing the right to receive one share of common stock per unit upon future vesting.
Ormat Technologies executive Jessica Woelfel, the company's GC, CCO, and CS, reported two open-market sales of common stock. On March 2, 2026, she sold 869 shares at $104.59 per share to cover tax withholding tied to Restricted Stock Units that vested on March 1, 2026. On March 3, 2026, she sold 2,359 shares at $105.16 per share under a pre-arranged Rule 10b5-1 trading plan. After these transactions, she directly owned 3,433 Ormat shares.
Benyosef Ofer reported acquisition or exercise transactions in this Form 4 filing.
Ormat Technologies executive Benyosef Ofer reported multiple equity award events dated March 1, 2026. Several tranches of restricted stock units and performance stock units vested and were settled into common stock at no cash cost, increasing his directly held common shares to 4,418.
The vested awards come from grants made on March 1, 2022 and other prior grants that vest over four-year and three-year schedules based on time and performance conditions. In addition, he received a new grant of 3,763 time-vesting RSUs that vest in roughly equal installments over the first, second and third anniversaries of the grant date.
ORMAT TECHNOLOGIES, INC. reported equity awards and vesting activity for executive Jessica Woelfel, its GC, CCO, and CS. On March 1, 2026, multiple batches of previously granted Restricted Stock Units (RSUs) and Performance Stock Units (PSUs) vested, and were converted into shares of common stock at a price of $0.00 per share.
The filing shows derivative exercises of RSUs totaling several small grants, alongside the fourth and final vesting installment of PSUs originally granted on March 1, 2022 and earned based on performance criteria. After these conversions, Woelfel directly owned 6,661 shares of common stock. In addition, she received a new grant of 4,980 time‑vesting RSUs on March 1, 2026, which are scheduled to vest in three annual installments.
ORMAT TECHNOLOGIES, INC. Chief Executive Officer Doron Blachar reported multiple equity compensation transactions dated March 1, 2026. Several tranches of Restricted Stock Units (including performance-based units) vested and were converted into shares of common stock at a price of $0.00 per share, consistent with equity award terms. In addition, he received a new grant of 12,653 time-vesting RSUs scheduled to vest in three annual installments. Following these conversions, Blachar directly owned 46,483 shares of Ormat common stock and held the new RSU award.
ORMAT TECHNOLOGIES, INC. Chief Financial Officer Assi Ginzburg reported multiple equity incentive transactions dated March 1, 2026. Several blocks of previously granted restricted stock units and performance stock units vested and were settled into a total of 5,030 shares of common stock at no cash exercise price.
The filing also shows a new award of 5,953 time-vesting RSUs granted on March 1, 2026, which will vest in roughly equal installments over three years as described in the footnotes. Following these transactions, Ginzburg directly owns 9,512 shares of common stock and 5,953 RSUs.
Willis Aron John reported acquisition or exercise transactions in this Form 4 filing.
ORMAT TECHNOLOGIES, INC. executive Aron John Willis, EVP of the Electricity Segment, received a grant of 3,463 restricted stock units. Each unit represents one share of ORA common stock upon vesting. The award vests over three years, with 33.3% vesting on the first and second anniversaries of the March 1, 2026 grant date and 33.34% vesting on the third anniversary.
Ormat Technologies (ORA) reported insider transactions by its GC, CCO, and Corporate Secretary. On November 7, 2025, the officer exercised 1,000 Stock Appreciation Rights (SARs) at an exercise price of $71.15 and received 368 shares, then sold 368 shares in open-market trades at a weighted average price of $112.36. On November 10, 2025, the officer exercised 1,889 SARs at $71.15 and received 721 shares, then sold 721 shares at $115.00.
Following these transactions, the officer beneficially owned 3,433 shares of common stock directly. Derivative holdings reflected remaining SARs of 962 expiring on March 1, 2028. The filing notes that the sale prices on November 7 were executed across multiple trades within the $112.35–$112.39 range.
Ormat Technologies (ORA): The Chief Financial Officer reported an open‑market sale of common stock. On 11/07/2025, the officer sold 20,000 shares (Transaction Code S) at a weighted average price of $112.725, with trades executed between $112.53 and $113.03. Following the sale, the officer beneficially owned 4,482 shares, held directly.
Ormat Technologies (ORA) reported an insider transaction on Form 4. The company’s EVP, Energy Storage & BD, sold 511 shares of common stock in an open‑market trade on November 7, 2025 at a price of $113.3 per share. Following the sale, the reporting person beneficially owns 1,110 shares, held directly.
Ormat Technologies (ORA) reported an insider transaction on a Form 4. A director sold 1,753 shares of common stock on 11/07/2025, coded S for an open-market sale at a price of $112.54 per share. Following the transaction, the insider reported 0 shares beneficially owned with direct (D) ownership. A footnote states the shares were sold in the open market on November 7, 2025.
Ormat Technologies (ORA) — Form 4 insider sale: A director reported selling 18,018 shares of common stock in open‑market transactions on 11/07/2025 at a weighted average price of $112.4247. The trades occurred across multiple executions between $112.23 and $112.775.
Following these transactions, the reporting person beneficially owned 29,650 shares, held directly.
Ormat Technologies (ORA) executive (EVP, Energy Storage & BD) reported insider transactions on 11/05/2025. The reporting person exercised Stock Appreciation Rights (SARs) covering 21,271 shares at an exercise price of $68.34 (expiring 05/12/2026) and 3,300 shares at $71.15 (expiring 03/01/2028).
Following the exercises, the filing shows dispositions tied to the SAR mechanics of 12,640 shares and 2,041 shares at a market value of $115. In addition, 9,890 shares were sold in the open market at $115 pursuant to a Rule 10b5-1 plan adopted on 06/26/2025. After these transactions, the reporting person directly beneficially owned 1,621 shares. The derivative table indicates 1,101 SARs remain beneficially owned.
Insider transaction summary: Ormat Technologies CEO Doron Blachar exercised 45,365 Stock Appreciation Rights (SARs) on 09/29/2025 with an exercise price of $63.40 and a market value of $94.71, resulting in issuance of 14,994 shares. Following these transactions and a concurrent open-market sale, the reporting person beneficially owned 35,419 shares. The SARs exercised were part of awards exercisable from 07/01/2022 and expiring 07/01/2026. The sale of 14,994 shares was executed under a 10b5-1 trading plan adopted 06/30/2025 at a weighted-average price of $94.71.
Insider activity summary: Director Stanley Stern exercised 1,210 stock appreciation rights (SARs) with an exercise price of $76.87, based on SARs that expire November 6, 2025. The exercise used the market value on the exercise date of $94.83 to determine payout, resulting in issuance of 229 common shares and a cash settlement for the remaining economic value equivalent to 981 shares. On the same day, 229 shares were sold at $94.83, and an additional 400 shares were sold on September 30, 2025 at $95.98. After these transactions, Mr. Stern beneficially owned 4,861 shares.
Assi Ginzburg, Chief Financial Officer of Ormat Technologies, Inc. (ORA) reported an open-market sale of 9,343 shares of the company’s common stock on 09/18/2025. The filing states these shares were sold in multiple transactions at a weighted average price of $93.31, with individual trade prices ranging from $93.30 to $93.375. After the reported disposals, the reporting person beneficially owns 24,482 shares. The Form 4 was signed by an attorney-in-fact and includes an undertaking to provide detailed trade-by-trade breakdowns to the company, securityholders, or the SEC staff upon request.
David Granot, a director of Ormat Technologies (ORA), exercised 1,210 Stock Appreciation Rights (SARs) on 08/21/2025. Upon exercise he delivered 1,011 shares back to the issuer to cover the exercise price and sold the remaining 199 shares in the open market the same day. The Form 4/A amends a prior Form 4 filed 08/25/2025 to correct an administrative error: the previously reported post-transaction beneficial ownership amounts were overstated by 838 shares and have been reduced accordingly. The SARs exercised had a grant price of $76.87 and expire on 11/06/2025.